Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1915-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 181, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
EIF4G2 hsa-miR-1915-5p low: 0 high: 5 1 1 1 0.740
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:10799003-10799022 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:10799003-10799022 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:10799003-10799022 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:10799003-10799022 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:10799003-10799022 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RHEBL1 hsa-miR-1915-5p low: 0 high: 5 1 1 1 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:49064904-49064917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:49064904-49064917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr12:49064904-49064917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:49064904-49064917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr12:49064904-49064917 HITS-CLIP POSITIVE DIRECT TarBase 7.0
IGF2BP1 hsa-miR-1915-5p low: 0 high: 3 1 1 1 0.727
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:49052514-49052534 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:49051061-49051087 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:49051061-49051087 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RNF11 hsa-miR-1915-5p low: 0 high: 2 1 1 1 0.471
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:51271730-51271749 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:51271730-51271749 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PTGES2 hsa-miR-1915-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr9:128120726-128120754 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:128120726-128120754 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NDOR1 hsa-miR-1915-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr9:137215503-137215523 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:137206293-137206315 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MSL1 hsa-miR-1915-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:40135602-40135629 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:40135602-40135629 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATXN1L hsa-miR-1915-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr16:71856745-71856769 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:71856745-71856769 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MAZ hsa-miR-1915-5p low: 0 high: 2 1 1 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr16:29809745-29809770 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr16:29807621-29807644 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KRIT1 hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:92245421-92245441 HITS-CLIP POSITIVE DIRECT TarBase 7.0
REV3L hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:111331674-111331700 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LZTS1 hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr8:20249392-20249412 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SNX13 hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr7:17940329-17940355 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ATP6AP1 hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chrX:154434425-154434452 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FSCN1 hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr7:5605368-5605385 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SENP1 hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr12:48043151-48043178 HITS-CLIP POSITIVE DIRECT TarBase 7.0
LRRC16A hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:25600597-25600622 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF264 hsa-miR-1915-5p low: 0 high: 1 1 1 1 0.489
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:57213272-57213300 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FBXL19 hsa-miR-1915-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:30947290-30947310 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CRKL hsa-miR-1915-5p low: 0 high: 1 1 1 1 0.465
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr22:20952233-20952254 HITS-CLIP POSITIVE DIRECT TarBase 7.0